October 21, 2024 at 1:00 pm US EDT
Leslie V. Boyer, MD, is a graduate of Harvard Medical School, a Professor Emerita of the University of Arizona, and a clinical and translational researcher whose academic contributions have been almost exclusively in the realm of rare diseases, particularly the impact and treatment of injury from the venom of snakes and scorpions. Beginning in 2024, she is also the Senior Vice President for Translational Science of Ophirex, a public benefit corporation focused on global health. Dr. Boyer led the team that developed the online Antivenom Index, an informational resource for US and Canadian zoos and poison centers in the management of non-native envenomations. She has been involved in the development, testing and FDA approval of scorpion antivenom AnascorpTM, pit viper antivenoms CroFabTM and AnavipTM, and a variety of other treatments for snake and arthropod envenomation worldwide. She has been named an Elsevier Speaker by the International Society on Toxinology, a Local Legend of Medicine by the American Medical Women’s Association and the U.S. National Library of Medicine, and a Rare Disease Hero by the FDA Office of Orphan Products.
Comments